Profound Medical (PROF) Net Income towards Common Stockholders (2024 - 2026)

Profound Medical's Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at $7.1 million for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 34.23% year-over-year to $7.1 million in Q1 2026; TTM through Mar 2026 was $60.3 million, a 33.73% increase from a year earlier, with the FY2025 full-year figure at $42.6 million, up 53.04% from the prior year.
• Net Income towards Common Stockholders fell to $7.1 million in Q1 2026 per PROF's latest filing, from $77.0 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $77.0 million in Q4 2025 and bottomed at -$15.7 million in Q2 2025.
• The 3-year median for Net Income towards Common Stockholders is -$6.6 million (2024), against an average of $11.0 million.
• Biggest YoY gain for Net Income towards Common Stockholders was 262.85% in 2025; the steepest drop was 126.84% in 2025.
• Year by year, Net Income towards Common Stockholders stood at $50.7 million in 2024, then jumped by 51.85% to $77.0 million in 2025, then sank by 90.84% to $7.1 million in 2026.
• Per Business Quant, the three latest PROF Net Income towards Common Stockholders figures stand at $7.1 million (Q1 2026), $77.0 million (Q4 2025), and -$8.0 million (Q3 2025).